Notably, in cancers with significantly upregulated miR-944 (BLCA, HNSC, and LUSC), the expression level of miR-944 was at Q4, higher than that of most miRNAs, and miR-944 expression was positively correlated with TP63 CNV. Here, TP63 is linked to cancer.